Academic · Private company · Houston, TX, US
Burzynski Research Institute Inc
SEC CIK 0000724445
Track this companyFree. Adds Burzynski Research Institute Inc to your Dealase workspace and tells you when its record changes.
Clinical trials40 recruiting or active
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Clinical trials4
- A Study of Atengenal and Astugenal in Diffuse, Intrinsic Pontine Glioma (DIPG)PHASE2 · SUSPENDED · started Apr 13, 2016ClinicalTrials.gov NCT02742883 · fetched Nov 12, 2026
- Antineoplaston Therapy in Treating Children With Brain TumorsPHASE2 · COMPLETED · started Sep 1, 1996ClinicalTrials.gov NCT00003458 · fetched Nov 12, 2026
- Antineoplaston Therapy in Treating Children With Low-Grade AstrocytomaPHASE2 · COMPLETED · started Jul 1, 1996ClinicalTrials.gov NCT00003468 · fetched Nov 12, 2026
- Antineoplaston Therapy in Treating Patients With EpendymomaPHASE2 · TERMINATED · started Jul 1, 1966ClinicalTrials.gov NCT00003479 · fetched Nov 12, 2026
SEC filings9
- 8-K · FORM 8-KSEC EDGAR · filed May 12, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Apr 23, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Jan 13, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Oct 14, 2025 · fetched Nov 12, 2026
- 8-K/A · FORM 8-K/ASEC EDGAR · filed Sep 11, 2025 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Jul 24, 2025 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Jul 15, 2025 · fetched Nov 12, 2026
- 10-K · 10-KSEC EDGAR · filed May 20, 2025 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Jan 13, 2025 · fetched Nov 12, 2026